The high-throughput sequencing technology was performed after the treatment of human osteosarcoma cells U2OS and MG63 with the active compound B5 designed and synthesized by ourselves, to explore the expression of genes related to cell adhesion, migration and invasion of human osteosarcoma cells U2OS and MG63 after the treatment of the active compound Changes to explore the effect of active compounds on the motility of osteosarcoma cells. SOURCE: zhi guo liu (lzgcnu@wmu.edu.cn) -  Wenzhou Medical University

Pluto Bioinformatics

GSE156729: High-throughput sequencing of OS cells treated with activated compound B5.